Published in J Urol on December 01, 1990
Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47
Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19
Deferred treatment of low grade stage T3 prostate cancer without distant metastases. J Urol (1993) 2.07
S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry (1990) 2.07
Early detection of malignancy in ulcerative colitis. A flow-cytometric DNA study. Cancer (1984) 1.80
Recent results of management of palpable clinically localized prostate cancer. Cancer (1993) 1.78
Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study. Acta Pathol Microbiol Immunol Scand A (1983) 1.46
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
The natural course of prostatic carcinoma in relation to initial cytological grade. J Urol (1988) 1.38
Ploidy and proliferation in human bladder tumors as measured by flow-cytofluorometric DNA-analysis and its relations to histopathology and cytology. Cancer (1979) 1.37
Deferred treatment of clinically localized low grade prostate cancer: the experience from a prospective series at the Karolinska Hospital. J Urol (1994) 1.17
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer (1986) 1.13
An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry (1991) 1.10
The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases. Br J Urol (1982) 1.07
Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol (1990) 1.05
Neoplastic transformation of the pelvic pouch mucosa in patients with ulcerative colitis. Gastroenterology (1997) 1.03
Flow cytofluorometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol (1982) 1.01
Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology. Anal Cell Pathol (1998) 1.01
Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy (2002) 1.00
Dysplasia and DNA aneuploidy in a pelvic pouch. Report of a case. Dis Colon Rectum (1991) 1.00
Deferred treatment in clinically localised prostatic carcinoma. Br J Urol (1992) 1.00
p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry. Gynecol Oncol (1994) 0.99
Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res (1999) 0.98
S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome. Cancer (1996) 0.94
Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry (1993) 0.93
Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res (1989) 0.93
Flow cytometric DNA analysis in longstanding ulcerative colitis: a method of prediction of dysplasia and carcinoma development? Gut (1987) 0.93
Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? J Hepatol (2000) 0.93
Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother (1984) 0.93
Investigation on cell proliferation with a new antibody against thymidine kinase 1. Anal Cell Pathol (2001) 0.92
Characterization of a peptide antibody against a C-terminal part of human and mouse cytosolic thymidine kinase, which is a marker for cell proliferation. Eur J Cell Biol (1996) 0.91
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene (1994) 0.91
DNA ploidy and cell phase in human pituitary tumors. Cancer (1984) 0.91
DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum (1994) 0.91
DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res (1982) 0.90
Deoxyribonucleic acid profile and tumor progression in primary carcinoma in situ of the bladder: a study of 63 patients with grade 3 lesions. J Urol (1992) 0.89
DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology (1992) 0.88
Flow-cytometric DNA analysis as a means for early detection of malignancy in patients with chronic ulcerative colitis. Gut (1984) 0.88
Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol (1996) 0.88
Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy. Prostate (1999) 0.87
DNA microspectrophotometry of bone sarcomas in tissue sections as compared to imprint and flow DNA analysis. Cytometry (1986) 0.87
Quantitative flow-microfluorometric analysis of the DNA in cells from neoplasms of the urinary bladder: correlation of aneuploidy with histological grading and the cytological findings. Urol Res (1978) 0.87
Clinical utility of cellular DNA measurements in prostate carcinoma. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993. Scand J Urol Nephrol Suppl (1994) 0.87
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of hydroxyurea on mutant and wild-type mouse S49 T-lymphoma cells. Exp Cell Res (1987) 0.86
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas. Clin Cancer Res (2000) 0.86
Quantitative analysis of antiviral drug toxicity in proliferating cells. Cell Biol Toxicol (1986) 0.86
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma. Br J Cancer (1999) 0.86
Morphometry of nuclei of the normal and malignant prostate in relation to DNA ploidy. Anal Quant Cytol Histol (1992) 0.85
Comparative single cell and flow DNA analysis in aspiration biopsies from breast carcinomas. Acta Pathol Microbiol Scand A (1980) 0.85
DNA measurements of human pituitary tumours. Acta Otolaryngol Suppl (1981) 0.84
Chromosomal and DNA patterns in transitional cell bladder carcinoma. A comparative cytogenetic and flow-cytofluorometric DNA study. Cancer (1984) 0.84
The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. J Urol (1990) 0.84
Analysis of cell flow and cell loss following X-irradiation using sequential investigation of the total number of cells in the various parts of the cell cycle. Cell Tissue Kinet (1985) 0.84
Deoxyribonucleoside triphosphate metabolism and the mammalian cell cycle. Effects of thymidine on wild-type and dCMP deaminase-deficient mouse S49 T-lymphoma cells. Exp Cell Res (1984) 0.84
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients. Br J Cancer (1999) 0.84
Deoxyribonucleic acid analysis in the evaluation of transitional cell carcinoma before cystectomy. J Urol (1984) 0.84
Hydroxyurea-induced cell death as related to cell cycle in mouse and human T-lymphoma cells. Cancer Res (1987) 0.84
Characterization of bladder carcinomas by flow DNA analysis. Eur Urol (1985) 0.83
Cell cycle related studies on thymidine kinase and its isoenzymes in Ehrlich ascites tumours. Cell Prolif (1991) 0.83
DNA content prognostic in soft tissue sarcoma. 102 patients followed for 1-10 years. Acta Orthop Scand (1991) 0.83
Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Int J Cancer (1983) 0.83
Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancers. Anticancer Res (1994) 0.83
DNA flow analysis of soft tissue tumors. Cancer (1987) 0.83
Consensus review of the clinical utility of DNA cytometry in bladder cancer. Report of the DNA Cytometry Consensus Conference. Cytometry (1993) 0.83
Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells. Exp Cell Res (1982) 0.83
Flow cytometric DNA and cytogenetic studies in human tumors: a comparison and discussion of the differences in modal values obtained by the two methods. Cytometry (1986) 0.83
p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res (1994) 0.83
DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol (1982) 0.83
Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression. Anticancer Res (1996) 0.82
Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 0.82
Comparative single-cell and flow DNA analysis of bone sarcoma. Anal Quant Cytol (1981) 0.81
X-irradiation effects on thymidine kinase (TK): I. TK1 and 2 in normal and malignant cells. Cell Prolif (2002) 0.81
Effects of foscarnet on the cell kinetics of Madin-Darby canine kidney cells. Biochim Biophys Acta (1983) 0.81
Cell cycle distribution of proliferative and functional cells of the rat jejunum after treatment with oral E2 prostaglandins. Scand J Gastroenterol (1987) 0.81
Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II. Anticancer Res (1992) 0.81
Carcinoma and DNA aneuploidy in Crohn's colitis--a histological and flow cytometric study. Gut (1991) 0.81
Assessment of cell proliferation by Ki-67 staining and flow cytometry in fine needle aspirates (FNAs) of reactive lymphadenitis and non-Hodgkin's lymphomas. Cytopathology (1999) 0.81
Evaluation of tumor heterogeneity of prostate carcinoma by flow- and image DNA cytometry and histopathological grading. Anal Cell Pathol (2000) 0.81
Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res (1991) 0.80
Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin. Cancer Res (1982) 0.80
Lack of correlation between thymidine kinase activity and changes of DNA synthesis with tumour age: an in vivo study in Ehrlich ascites tumour. Cell Tissue Kinet (1990) 0.80
Flow cytometry and interactive image cytometry in endometrial carcinoma. A comparative and prognostic study. Anticancer Res (1991) 0.80
Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases. Urology (1998) 0.80
Prognostic value of deoxyribonucleic acid content in prostate cancer: a review of current results. Int J Cancer (1994) 0.80
Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic classification. Cancer (1984) 0.80
Prediction of lymph node metastases in bladder carcinoma with deoxyribonucleic acid flow cytometry. J Urol (1990) 0.80
Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate (1998) 0.79
Aneuploid DNA pattern in human pituitary adenomas. Arch Otorhinolaryngol (1981) 0.79
Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer. Eur Urol (2000) 0.79
DNA pattern of human pituitary tumors. Am J Otolaryngol (1985) 0.79
Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance. Gynecol Oncol (1989) 0.79
Influence of human alpha-interferon on four human osteosarcoma xenografts in nude mice. Cancer Res (1985) 0.79
Non-tumorigenic SV40T immortalized human buccal epithelial cells show aneuploidy and genetic instability. Anticancer Res (1996) 0.79
Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet (1994) 0.79
DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories. Cytometry (1992) 0.79
Failure to detect immunologic stigmata in schizophrenia. Neuropsychobiology (1982) 0.79
S-phase lymphocytes in chronic lymphocytic leukemia (CLL) in relation to immunoglobulin isotypes on the leukemic clone and to disease activity. Leukemia (1987) 0.79
Hydroxyurea-induced cell death in human T lymphoma cells as related to imbalance in DNA/protein cycle and deoxyribonucleotide pools and DNA strand breaks. Anticancer Drugs (1992) 0.78